Skip to content
Markets News
Stocks1 min read

Teladoc Slides 2.38% as Quarterly Earnings Estimates Approach

Makkler Newsroom
September 29, 2026

The telehealth provider fell more than the S&P 500, while Zacks' next-quarter estimates point to lower earnings and revenue.

Teladoc Health shares fell 2.38% to close at $5.75 in the latest session, underperforming the S&P 500, which lost 0.17%. The telehealth provider also trailed the Dow and Nasdaq, which fell 0.26% and 0.09%, respectively.

Over the past month, Teladoc's stock has fallen 7.1%. The Medical sector declined 0.67% over the same period, while the S&P 500 slipped 0.24%.

Investors are awaiting the company's next earnings release. Zacks' consensus estimate calls for a quarterly loss of 23 cents per share, down 9.52% year over year, and revenue of $585.55 million, a 6.53% decline.

For the full year, Zacks' consensus forecast is earnings of -$0.92 per share and revenue of $2.4 billion. The estimates imply a 19.3% year-over-year increase in earnings and a 5.03% drop in revenue.

The consensus estimate for earnings per share has fallen 1.62% over the past 30 days, according to Zacks.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.